Quality of life and occupational disability in endocrine orbitopathy
- PMID: 19547630
- PMCID: PMC2689575
- DOI: 10.3238/arztebl.2009.0283
Quality of life and occupational disability in endocrine orbitopathy
Abstract
Background: In endocrine orbitopathy (EO), disfiguring proptosis and diplopia impair patients' quality of life both at home and at work.
Methods: From late 2006 to the beginning of 2008, 250 outpatients in an interdisciplinary thyroid and eye clinic filled out a questionnaire about their quality of life, occupational disability, and use of psychotherapy. 400 physicians who referred their EO patients to the clinic also participated in a survey on these issues.
Results: 45% of the patients complained of restrictions in their daily activities, and 38% reported impaired self-perception. 36% were on sick leave because of EO. 28% were disabled, 5% had retired early, and 3% had lost their jobs. Patients with severe EO and motility disorders were on sick leave for longer times and were more likely to be disabled. 21% underwent psychotherapy. Patients who had been on sick leave for a long time and/or were disabled were more likely to undergo psychotherapy. Among the physicians answering the survey, 75% stated that they were taking care of temporarily disabled patients, while 34% were taking care of permanently disabled patients. 38% were treating EO patients who were undergoing psychotherapy.
Conclusions: These data indicate that patients with EO suffer considerable emotional stress and occupational impairment and point to the need for preventive care and rapid rehabilitation.
Keywords: Graves’ disease; endocrine orbitopathy; impaired earning capacity; occupational disability; quality of life.
Figures
 
              
              
              
              
                
                
                 
              
              
              
              
                
                
                 
              
              
              
              
                
                
                 
              
              
              
              
                
                
                References
- 
    - Dickinson AJ. Clinical manifestations. In: Wiersinga WM, Kahaly GJ, editors. Graves’ orbitopathy—a multidisciplinary approach. Basel: Karger-Verlag; 2007. pp. 1–26.
 
- 
    - Bartley GB, Fatourechi V, Kadrmas EF, et al. Chronology of Graves’ ophthalmopathy in an incidence cohort. Am J Ophthalmol. 1996;121:426–434. - PubMed
 
- 
    - Ponto KA, Kahaly GJ. Endokrine Orbitopathie - Aktuelle Diagnostik und Therapie. Med Klin. 2008;103:717–730. - PubMed
 
- 
    - Ponto KA, Kahaly GJ, Pitz S. Update endokrine Orbitopathie. Klin Monatsbl Augenheilkd. 2009;226 R13-28; quiz R29-31. - PubMed
 
- 
    - Coulter I, Frewin S, Krassas GE, Perros P. Psychological implications of Graves’ orbitopathy. Eur J Endocrinol. 2007;157:127–131. - PubMed
 
Publication types
MeSH terms
LinkOut - more resources
- Full Text Sources
 
        